A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
about
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous systemEfficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vectorNeuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neuronsTransplantation of hypocretin neurons into the pontine reticular formation: preliminary resultsTargeting neural precursors in the adult brain rescues injured dopamine neuronsParkinson's disease and primate research: past, present, and futureThe role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatmentDiscovery of nigral dopaminergic neurogenesis in adult miceA Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesIncreased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell ImagingFoetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced DyskinesiaThe Progress of Induced Pluripotent Stem Cells as Models of Parkinson's DiseaseStriatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseCell Therapy for Parkinson's Disease: New Hope from Reprogramming TechnologiesPotential of Neural Stem Cell-Based Therapy for Parkinson's DiseaseStem cell transplantation therapy in Parkinson's diseaseImmortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neuronsParkinson's disease gene therapy: success by design meets failure by efficacyAdult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticityPluripotent stem cells in regenerative medicine: challenges and recent progressThe glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?The development, past achievements, and future directions of brain PETCell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's diseaseStem cells in human neurodegenerative disorders--time for clinical translation?Time to change the blind men and the elephant approach to Parkinson disease?Critical review of sham surgery clinical trials: Confounding factors analysisThe magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysisGrowth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20Ectopic pregnancy-derived human trophoblastic stem cells regenerate dopaminergic nigrostriatal pathway to treat parkinsonian ratsChemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's DiseaseWhat happened to posteroventral pallidotomy for Parkinson's disease and dystonia?Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic ProgenitorsWnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.Ethical issues in stem cell research.Sham surgery trial controls: perspectives of patients and their relatives.Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques.Human neural stem cells survive long term in the midbrain of dopamine-depleted monkeys after GDNF overexpression and project neurites toward an appropriate target.
P2860
Q21129488-41314709-3486-4755-BE85-9849B8A87A44Q21134939-7EEF5E09-DD7D-4420-9319-A0E96C2A313DQ21262040-454F69D8-7DE9-4388-9141-DFE296C53CDCQ24532097-4040CC2E-9605-4DBC-BD63-92A0A68DB26DQ24646096-C860FB19-AE8E-4FF1-A6D0-79A426452A12Q24655590-6C50AA7E-9B75-48C9-92DB-89B6D87B4CBFQ24675617-7F6464FF-A3DA-4BCA-A9E7-3796E06AC829Q26740094-5DBB01F0-63C3-4328-91D9-114EE0F20643Q26746033-F5B441E2-CE1D-4975-A0AC-178EF40C829BQ26747508-6460D5F3-1957-4766-87D2-1DBF04DD2A3FQ26753150-BBCEEA82-CF43-48D7-9F9D-9B11A131B29EQ26765499-68363387-EA5B-491E-ACEE-1086DB61F5B3Q26765894-4F15D297-6745-485D-8C78-71087F7609B0Q26768220-6889BA99-8D46-4C06-AD88-47506E19E962Q26773485-6347DA16-8E58-4623-977C-D0CFB5710C42Q26776041-03EDAF56-E477-45A7-807D-F19DB5B1551DQ26776154-D5AC3FA2-F55C-4D4F-A0F9-FFD0DD7470DCQ26778682-EE8582F2-F916-4ADF-8FCE-63D134C36DC6Q26829548-BFA9535F-EF56-4FE1-9D8D-0747B1443958Q26851325-6050EC46-9790-48A2-89CF-263BC92DD3BAQ26862840-8C87C571-3422-4372-AAC3-F4BBE21D02DEQ26999292-DC605B26-71C0-4A20-AD60-D3328FFA3AD5Q27023715-1ACDAA8C-45C6-4825-AB9E-395AB497AFD3Q27024152-FF3A734F-C938-476A-AAEE-12E7BD72F975Q27026331-7CC96294-2E89-4B4C-B454-B74057ACAFFEQ27334576-0F21EDC6-283E-4F01-B3E4-61BC1ACAE381Q27687068-F1230A87-4341-4FC8-A078-B39D740386CAQ27693350-6B93C6D5-7702-4899-BEFA-03B98CF2243FQ28071434-0A707F51-3A81-4E96-8A41-A0FEB25C1E59Q28072743-B99DC03D-C8DD-41AE-9FE4-329D67413FC0Q28115686-8CEA59A2-193C-4314-B8A3-EBC914AFD3EDQ28484528-C0A279DF-6A67-47DC-9211-0E0CE9E56EEBQ28829174-6C2C9019-2BA5-43A4-803E-15A63A0CC569Q30371432-59CE52C5-F5F8-4A03-A85F-A8E3C5721A36Q30377980-018FE8FA-979D-4F70-BCBE-C19D975B3C7BQ30480781-6AC2FCDE-894B-4DD1-AF7B-0617B6B9A9FDQ30489527-29337575-4217-40CF-A047-C1795D62B918Q30530288-1F4A6B94-34BE-4DD7-97FF-6B2F90EC2D69Q30530883-DD7ACCDE-C57C-41F0-9D96-283F18ADCFF5Q30579312-56072705-471B-44BF-918F-FBEDB5299E82
P2860
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A double-blind controlled tria ...... tation in Parkinson's disease.
@en
A double-blind controlled tria ...... tation in Parkinson's disease.
@nl
type
label
A double-blind controlled tria ...... tation in Parkinson's disease.
@en
A double-blind controlled tria ...... tation in Parkinson's disease.
@nl
prefLabel
A double-blind controlled tria ...... tation in Parkinson's disease.
@en
A double-blind controlled tria ...... tation in Parkinson's disease.
@nl
P2093
P50
P356
P1433
P1476
A double-blind controlled tria ...... tation in Parkinson's disease.
@en
P2093
A Jon Stoessl
Daniel P Perl
G Michael Nauert
James Godbold
Kathleen M Shannon
Mitchell F Brin
Thomas B Freeman
P304
P356
10.1002/ANA.10720
P577
2003-09-01T00:00:00Z